Reshaping pharmaceutical quality ( The first scientific papers outlinin...)

Reshaping pharmaceutical quality

Date:6/2/2008

The first scientific papers outlining the progress made on the Product Quality Lifecycle Implementation (PQLI) initiative are being published in the June 2008 issue of the Journal of Pharmaceutical Innovation (JPI). Written by experts representing the global pharmaceutical manufacturing industry, these papers present practical scientific and technological approaches to implementing ICH* documents that address pharmaceutical development, quality risk management and pharmaceutical quality systems. The June issue will be published in print and is available free of charge on Springer's electronic information platform SpringerLink at http://www.springerlink.com/content/1939-8042 with the possibility to comment.

The PQLI initiative was launched by the International Society for Pharmaceutical Engineering (ISPE) in June 2007 to help industry find practical technical solutions to the challenges of implementing guidelines put forth by the ICH. The first three task teams formed focused on criticality, design space and control strategy, and how these areas are linked; a Legacy Products Task Team has also been formed as the fourth topical area. PQLI is projected to be at least a five-year initiative that has started with interactive fact-gathering sessions held in the USA and Europe. For background information on the PQLI papers, please see http://springer.com/12247.

The criticality study describes a mechanism for categorizing and delineating criticality for quality attributes, variables, material attributes and process parameters in accordance with a risk-based approach reflective of quality by design (QbD) principles. Design space discussions considered the linkage of the patient experience with product quality. The Control Strategy Team has proposed a model process to enable a clear logic to be used on how a control strategy differentiates between
'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
2. Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
3. Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence
4. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
5. KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings
6. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
7. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
8. Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008
9. FDLI Publishes Comprehensive Handbook on Pharmaceutical Risk Management
10. Research Study Shows That Pharmaceutical Field Sales Reps Productivity Inhibited by Unnecessary Internal Communication
11. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results

Post Your Comments:

(Date:3/7/2014)... Institute of Texas has awarded the University of Texas ... continue a program aimed at creating a new state ... treatments and outcomes in Texas. , One of 11 ... UTMB award will fund the work of the organization ... more years. , Led by Dr. James Goodwin, ...

(Date:3/6/2014)... UNC,s Frank Porter Graham Child Development Institute ... produces significant positive outcomes for children, regardless ... skills. FPG,s research on nearly 1,200 children ... and general knowledge for students enrolled in ... findings demonstrate compelling evidence for the impact ...

(Date:3/6/2014)... has found cannabinoid receptors, through which marijuana exerts its ... involved in regulating anxiety and the flight-or-fight response. , ... identified in the central nucleus of the amygdala in ... of the journal Neuron . , The discovery ... the drug mainly to reduce anxiety, said Sachin Patel, ...

(Date:3/5/2014)... program from UNC,s Frank Porter Graham Child Development Institute ... autism for life after high school. , "Public high ... for adolescents with autismand for their families," said FPG ... face unemployment and few social ties after school ends." ... the schools work hard to achieve beneficial results for ...

(Date:3/5/2014)... cancer immunotherapy strategies designed to induce the ... provide a new and cost-effective weapon against some ... and mesothelioma. Investigators from the Massachusetts General Hospital ... Journal of Hematology & Oncology that ... a tumor-cell-surface antigen with another protein that stimulates ...

Breaking Medicine News(10 mins):Health News:UTMB receives $3.2 million to continue collaborative research on cancer in Texas 2 Health News:Large-scale study shows power of pre-k 2 Health News:Large-scale study shows power of pre-k 3 Health News:Discovery sheds new light on marijuana's anxiety relief effects 2 Health News:New program for students with autism offers hope after high school 2 Health News:Novel cancer vaccine holds promise against ovarian cancer, mesothelioma 2 Health News:Novel cancer vaccine holds promise against ovarian cancer, mesothelioma 3

[0] UTMB receives $3.2 million to continue collaborative research on cancer in Texas [0] Large-scale study shows power of pre-k [0] Discovery sheds new light on marijuana's anxiety relief effects [0] New program for students with autism offers hope after high school [0] Novel cancer vaccine holds promise against ovarian cancer, mesothelioma

... , THURSDAY, Sept. 15 (HealthDay News) -- Children typically don,t die ... Thursday that 115 kids younger than 18 died from flu-related causes ... many of the deaths could have been prevented if the children ... U.S. Centers for Disease Control and Prevention. , , ...

... protein linked to cell division and migration and tied to ... high levels in breast cancer specimens and cell lines. The ... in breast cancer cells than in normal breast cells. ... findings and others in a paper now online in the ...

... News) -- Experts around the world have issued a call ... A group of international medical bodies said physicians can ... and it also urged governments to take action and address ... in preventable and premature disease, affecting 76 million people globally. ...

... Clinic have received a grant from the National Institutes of ... test that conclusively identifies concussions in college football players. ... after a game searches for a biomarker known as ... in an athlete,s blood. Damir Janigro, Ph.D., and Nicola ...

... -- Not enough children and teens drink low-fat milk, a ... Prevention reveals. Drinking milk is important for children,s bone ... the calcium, vitamin D and other nutrients found in milk, ... milk products to avoid unnecessary fat and calories. ...

... In order to better prevent blood clots, the drugs ... acute ischaemia of the heart muscle, in addition to ... Efficiency in Health Care (IQWiG) has now investigated whether, ... coronary intervention (PCI), the combination of prasugrel plus ASA ...

Cached Medicine News:Health News:Flu Killed 115 Children Last Season: CDC 2 Health News:Flu Killed 115 Children Last Season: CDC 3 Health News:Study finds protein critical to breast cancer cell proliferation, migration 2 Health News:Doctors Urged to Lead Battle Against Alcohol Abuse 2 Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 2 Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 3 Health News:Not Enough Kids Drink Low-Fat Milk, U.S. Study Finds 2 Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 2 Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 3 Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 4

Flu Killed 115 Children Last Season: CDC Study finds protein critical to breast cancer cell proliferation, migration Doctors Urged to Lead Battle Against Alcohol Abuse Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test Not Enough Kids Drink Low-Fat Milk, U.S. Study Finds Prasugrel: Indications of an additional benefit for some patients, but also of greater harm

(Date:1/15/2014)... 2014 The Cadence Fitness & Health ... Center by the Medical Fitness Association, a non-profit ... to achieve their full potential. The Cadence Fitness ... center in the western suburbs and second in ... the Cadence Fitness & Health Center meets guidelines ...

(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ... aspects in today,s growth in the pharmaceutical ...

(Date:1/14/2014)... , Jan. 14, 2014 Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on ... results is scheduled for release after the close of ... Management will hold a conference call to discuss ... quarter and twelve months ended December 31, 2013 on ...

[0] Cadence Fitness & Health Center Certified as Medical Fitness Facility [0] Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users [0] Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014

... Feb. 28, 2012 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... will present a company overview at Cowen and Company,s 32nd ... 10:40 a.m. ET at the Boston Marriot Copley Place. ... be available on the "Investors & Media" section of the ...

... OncoSec Medical Incorporated (OTCBB: ONCS), which is developing ... treat solid tumor cancers, today announced that Investigational Review ... of California San Francisco and the first patient has ... OncoSec,s OMS ElectroImmunotherapy for the treatment of ...

Cached Medicine Technology:OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 2 OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 3 OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 4

Isis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma

... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...

Cardiology Intensive Board Review is geared specifically to candidates taking the Cardiovascular Boards and the Cardiovascular section of the Internal Medicine Boards....

... Consult is the perfect quick consult ... diagnosis and management of both common ... of chest pain to the management ... quick reference makes the most of ...

This is designed to synthesize current cardiovascular research findings for busy physicians and healthcare professionals....

Medicine Products:

Cochrane Reviews in Heart Cardiology Intensive Board Review The AHA Clinical Cardiac Consult ACCF Clinical Trials Database